(Takeda cTTP-2) A Phase 3b, open-label, continuation study of prophylactic and on-demand treatment of cTTP with TAK-755 (rADAMTS-13, also known as BAX 930/SHP655)

Administered By

Awarded By

Contributors

Start/End

  • January 5, 2022 - May 31, 2024